Navigation Links
Untreatable Eye Disease Improves With Avastin

Patients with radiation retinopathy who were destined to go blind within five years now can keep their sight longer through localized treatment with Avastin , a well-known cancer drug, according to a two-year study published in the June, 2007 Archives of Ophthalmology.

This is a major breakthrough for eye cancer patients who are treated with radiation therapy and commonly develop radiation retinopathy, said Paul T. Finger, MD, lead author of the study and director of Ocular Tumor Services at the New York Eye and Ear Infirmary. Avastin reduces abnormal blood vessel growth, stops leakage in the eye and the patients wind up seeing better. This is a first.

Until now, patients with inflammation or cancer of the eyes choroid, retina, orbit and paranasal sinuses were confronted with a catch-22 in terms of treatment. Radiation therapy is the treatment of choice for most patients; but, it commonly causes a troubling side effect -- radiation retinopathy.

Dr. Finger references in the study 6 patients who had plaque radiation therapy and developed radiation retinopathy, but he has now treated 28 patients successfully with Avastin, he says. The drug improved or stabilized visual acuity in all cases by dramatically reducing blood vessel leakage and resultant swelling of the macula, the major causes of irreversible vision loss in radiation retinopathy, he said. He also noted that, before these Avastin findings, there was no effective treatment for macular radiation retinopathy.

Avastin is a monoclonal anti-body which inhibits the formation of abnormal blood vessels by selectively blocking a substance known as vascular endothelial growth factor (VEGF). Avasitin (also called bevaciaumab) is used systemically (throughout the body) for some cancers and has been linked to the risk of stroke; but, in this new study, it was administered and stayed locally in the eye.

In February 2007, in a study published in The America
'"/>




Page: 1 2

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Vitamins-The answer to Heart Disease?
3. Link between Constipation and Parkinsons Disease
4. Levels Of Blood Proteins May Help Heart Disease Care
5. New Drug PP188 Helps Sickle Cell Disease
6. Gene Treatment for Heart Disease
7. Legume Consumption Can Cut Heart Disease Risk
8. Link Between Infection And Heart Disease
9. Celiac Disease in Type 1 Diabetes
10. Shunt for Alzheimers Disease
11. High iron levels may cause Cardiovascular Disease in women
Post Your Comments:
(Date:10/13/2008)...ER WITH THE VIPER RESPONDER LE SPECIAL ...VISTA, Calif., Oct. 13 /PRNewswire-FirstCall/ -- D...DEI Holdings Inc. (Nasdaq: DEIX ), has joined,the... of Responder LE,Special Edition 2-Way Vehicle Sec...g Susan G. Komen for the Cure. For each pink Respo...
(Date:10/13/2008)...han Alzheimer,s patients, healthy controls , ...nson,s disease patients are more likely than healt...D deficiency, say researchers from the Emory Unive...pared vitamin D levels in 100 Parkinson,s patients...atched for age and other factors. , "Significan...
(Date:10/13/2008)...IH funding advances study Study needed becau...LIS, Oct. 13 /PRNewswire/ -- Advanced Circulatory ... ) announced today that it has received,an additio...itutes of,Health (NIH) to continue a study testing...rience cardiac arrest outside a hospital. Parts of...
(Date:10/13/2008)...re/ -- The National Coalition for,Quality Colorect...rns over,the National CT Colonography Study publis...icine. The evidence must be closely evaluated, and...s not without significant,potential risks. The Nat...remains the "Gold Standard" for colorectal cancer ...
Breaking Medicine News(10 mins):Health News:Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month 2Health News:Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month 3Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3
...or for cardiovascular diseases.A potbelly indicate...f the rest of the body is skinny as a beanpole. T...isk is the relationship of waist size to the hips,...icts an increased risk of heart attack. The study ...
...immings of cloned pig’s bacon, a jar of cloned cow...er; ‘Frankenstein foods’, as some// refer to it. ...stration (FDA) of US is getting ready to pass a bi...animal products. “We based our decision on lookin...
...'s 2002 Gay Pride, San Francisco Department of Pub...arize syphilis testing. In the above said campaig...roduced to Gayville, encouraging the many hundreds...hered there to get themselves tested for the big-S...
... a weight reduction pill, which works better and f... risk of heart disease, diabetes and cancer. Exis...ve to 10 percent when taken for a year. But men a...e new pill developed by Californian biopharmaceuti...
Other Medicine News:Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2Health News:Clones On the Menu 2
(Date:10/10/2008)...INGTON and MENLO PARK, Calif., Oct. 10 /PRNewswire...announced that it plans to present,long-term follo...rials next,week at the Cardiovascular Research Fou...diovascular Therapeutics (TCT) meeting in Washingt... studies designed to investigate,the safety and ef...
(Date:10/10/2008)...SANTON, Calif., Oct. 10 /- TriReme Me...authorized to affix the CE (Conformite,Europeenne)...M) Coronary,Stent System, a unique main vessel ste...ronary bifurcations., Representing the next gener...tem has potential use in a quarter of the 2.2 mill...
(Date:10/9/2008)...pps Translational Science Institute, Navigenics, A...lth study, SAN DIEGO, Oct. 9 /- A co...eaders have joined forces in a first-of-its-kind,r...ersonal genetic testing,on people who choose to re...risk for developing certain diseases., Sponsored ...
(Date:10/8/2008)...ona Heart Institute Pioneers Research That May Off...ct. 8 /- Nationally, over 3,000 peopl...ease on life. Sadly, only half,of those will recei...na,Heart Institute (AHI) is paving the way for how..., To view the Multimedia News Release, go to:, ht...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Patient Safety Technologies Closes on 242 325 Million in Equity Financing 25845 1Patient Safety Technologies Closes on 242 325 Million in Equity Financing 25845 2Replidyne Announces Restructuring of Operations 25843 1Replidyne Announces Restructuring of Operations 25843 2VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 1VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 2VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 3New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 1New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 2New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 3New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 4New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 5New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 6
The VISUCAM non-mydriatic fundus camera increases the quality and simplicity of fundus imaging. Compact, yet big enough to set the standard in ophthalmic photography, it features a unique combination
The Afinion HbA1c test and the fully automated Afinion Analyzer, give you reliable facts conveniently available when and where you need them. Advising the patient can be carried out with confidence.
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket.
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time.
Medicine Products: